Rainbow Seed Fund Invests in AgPlus Diagnostics
28 September 2016 AgPlus’ handheld electrochemical reader to deliver the next generation of rapid diagnostics…
read moreAgPlus Diagnostics has developed a diagnostic platform technology based on research conducted at the UK’s National Physical Laboratory (NPL).
AgPlus’ platform technology combines novel electrochemistry and metallic nanoparticles signalling with diagnostic immunoassays to provide high sensitivity and fully quantitative analyte detection. The AgPlus ADVANTAGE handheld portable reader and single-use test cartridge are expected to be used across multiple applications and sectors, critically where fast cost-effective diagnostic results will enable users to make decisions, with confidence, in minutes, not hours or days.
Status current
Associated Fund UK Innovation & Science Seed Fund
Sector Medical / Biotechnology
Website www.agplusdiagnostics.com/
28 September 2016 AgPlus’ handheld electrochemical reader to deliver the next generation of rapid diagnostics…
read moreThere is a need for rapid, accurate quantitative diagnostic tests within the health sector...
read moreThere is a need for rapid, accurate quantitative diagnostic tests within the health sector...
read moreA BIT ABOUT CATHERINE Catherine graduated with a 1st class Hons in Biochemistry from Nottingham...
read moreUpdate your browser to view this website correctly.Update my browser now